Hepatitis Monthly

Published by: Kowsar

Positive Role of Procalcitonin Level in the Diagnosis of Infectious Diseases After Liver Transplantation

Fereshteh Ghiasvand 1 , Simin Dashti-Khavidaki 2 , Bobak Moazzami 2 , * , Amirpasha Ebrahimi 2 , Zeynab Malekzadeh 1 , Zinat Mohammadpour 2 , Leila Jahan 2 , Mohsen Nasiri-Toosi 2 and Zahra Ahmadinejad 2 , **
Authors Information
1 Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2 Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Corresponding Authors:
Article information
  • Hepatitis Monthly: 19 (5); e85668
  • Published Online: May 20, 2019
  • Article Type: Research Article
  • Received: October 22, 2018
  • Revised: January 28, 2019
  • Accepted: May 10, 2019
  • DOI: 10.5812/hepatmon.85668

To Cite: Ghiasvand F , Dashti-Khavidaki S , Moazzami B, Ebrahimi A , Malekzadeh Z , et al. Positive Role of Procalcitonin Level in the Diagnosis of Infectious Diseases After Liver Transplantation, Hepat Mon. Online ahead of Print ; 19(5):e85668. doi: 10.5812/hepatmon.85668.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Kaido T, Egawa H, Tsuji H, Ashihara E, Maekawa T, Uemoto S. In-hospital mortality in adult recipients of living donor liver transplantation: Experience of 576 consecutive cases at a single center. Liver Transpl. 2009;15(11):1420-5. doi: 10.1002/lt.21873. [PubMed: 19877211].
  • 2. Ishigami M, Katano Y, Hayashi K, Ito A, Hirooka Y, Onishi Y, et al. Risk factors of recipient receiving living donor liver transplantation in the comprehensive era of indication and perioperative managements. Nagoya J Med Sci. 2010;72(3-4):119-27. [PubMed: 20942266].
  • 3. Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: Essentials. Liver Transpl. 2011;17 Suppl 3:S34-7. doi: 10.1002/lt.22378. [PubMed: 21748845].
  • 4. Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, et al. Complications and their resolution in recipients of deceased and living donor liver transplants: Findings from the A2ALL cohort study. Am J Transplant. 2016;16(2):594-602. doi: 10.1111/ajt.13479. [PubMed: 26461803]. [PubMed Central: PMC4733444].
  • 5. Kaido T, Ogawa K, Fujimoto Y, Mori A, Hatano E, Okajima H, et al. Perioperative changes of procalcitonin levels in patients undergoing liver transplantation. Transpl Infect Dis. 2014;16(5):790-6. doi: 10.1111/tid.12282. [PubMed: 25154523].
  • 6. van den Broek MA, Olde Damink SW, Winkens B, Broelsch CE, Malago M, Paul A, et al. Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit. Liver Transpl. 2010;16(3):402-10. doi: 10.1002/lt.21987. [PubMed: 20209599].
  • 7. Cooper D, Sharples L, Cornelissen J, Wallwork J, Alexander G, Trull A. Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation. Transplant Proc. 2001;33(1-2):1808-10. doi: 10.1016/S0041-1345(00)02690-7. [PubMed: 11267522].
  • 8. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ. 2005;331(7507):26. doi: 10.1136/bmj.38483.478183.EB. [PubMed: 15979984]. [PubMed Central: PMC558535].
  • 9. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11(3):152-9. doi: 10.1007/s10156-005-0388-9. [PubMed: 15990980].
  • 10. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515-8. doi: 10.1016/0140-6736(93)90277-N. [PubMed: 8094770].
  • 11. Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J. 2000;19(7):598-602. doi: 10.1097/00006454-200007000-00003. [PubMed: 10917215].
  • 12. Sandkovsky U, Kalil AC, Florescu DF. The use and value of procalcitonin in solid organ transplantation. Clin Transplant. 2015;29(8):689-96. doi: 10.1111/ctr.12568. [PubMed: 25996831].
  • 13. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis. Lancet Infect Dis. 2007;7(3):210-7. doi: 10.1016/S1473-3099(07)70052-X. [PubMed: 17317602].
  • 14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-40. doi: 10.1016/0196-6553(88)90053-3. [PubMed: 2841893].
  • 15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6. doi: 10.1097/01.CCM.0000050454.01978.3B. [PubMed: 12682500].
  • 16. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-10. doi: 10.1001/jama.2016.0287. [PubMed: 26903338]. [PubMed Central: PMC4968574].
  • 17. Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology. 1997;25(3):658-63. doi: 10.1002/hep.510250328. [PubMed: 9049215].
  • 18. Hladik M, Olosova A, Neiser J, Zaoral T. Procalcitonin-a marker and mediator of inflammation. Acta Chir Plast. 2005;47(2):51-4. [PubMed: 16033153].
  • 19. Sorbera LA. Procalcitonin as an effective biomarker for the diagnosis and prognosis of severe sepsis. Highlights from the 25th International Symposium on Intensive Care and Emergency Medicine. March 21-25, 2005, Brussels, Belgium. Drugs Today (Barc). 2005;41(4):253-6. doi: 10.1358/dot.2005.41.4.900160. [PubMed: 16034489].
  • 20. Suberviola B, Castellanos-Ortega A, Ballesteros MA, Zurbano F, Naranjo S, Minambres E. Early identification of infectious complications in lung transplant recipients using procalcitonin. Transpl Infect Dis. 2012;14(5):461-7. doi: 10.1111/j.1399-3062.2012.00780.x. [PubMed: 22897603].
  • 21. Yu XY, Wang Y, Zhong H, Dou QL, Song YL, Wen H. Diagnostic value of serum procalcitonin in solid organ transplant recipients: A systematic review and meta-analysis. Transplant Proc. 2014;46(1):26-32. doi: 10.1016/j.transproceed.2013.07.074. [PubMed: 24507021].
  • 22. Madershahian N, Wittwer T, Strauch J, Wippermann J, Rahmanian P, Franke UF, et al. Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg. 2008;23(5):468-73. doi: 10.1111/j.1540-8191.2008.00625.x. [PubMed: 18928484].
  • 23. Coelho MC, Tannuri U, Tannuri AC, Reingenheim C, Troster EJ. Is procalcitonin useful to differentiate rejection from bacterial infection in the early post-operative period of liver transplantation in children? Pediatr Transplant. 2009;13(8):1004-6. doi: 10.1111/j.1399-3046.2008.01102.x. [PubMed: 19032409].
  • 24. Mori Y, Miyawaki K, Kato K, Takenaka K, Iwasaki H, Harada N, et al. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting. Intern Med. 2011;50(19):2149-55. doi: 10.2169/internalmedicine.50.5798. [PubMed: 21963733].
  • 25. Perrakis A, Yedibela S, Schellerer V, Hohenberger W, Muller V. Procalcitonin in the setting of complicated postoperative course after liver transplantation. Transplant Proc. 2010;42(10):4187-90. doi: 10.1016/j.transproceed.2010.08.070. [PubMed: 21168660].
  • 26. Savas Bozbas S, Er Dedekarginoglu B, Ulubay G, Haberal M. Role of serum procalcitonin levels in solid-organ transplant patients. Exp Clin Transplant. 2016;14(Suppl 3):116-20. [PubMed: 27805529].
  • 27. Ahmadinejad Z, Dadsetan B, Jalili M, Soudbakhsh A, Rasolinejad M. Evaluation of serum procalcitonin in patients with systemic inflammatory response syndrome with and without infection. Acta Med Iran. 2009;47(5):383-8.
  • 28. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004;32(8):1715-21. doi: 10.1097/01.CCM.0000134404.63292.71. [PubMed: 15286549].
  • 29. Fazakas J, Gondos T, Varga M, Sarvary E, Horovitz P, Perner F. Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int. 2003;16(7):465-70. doi: 10.1007/s00147-002-0512-z. [PubMed: 12728303].
  • 30. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79(6):1605-8. doi: 10.1210/jcem.79.6.7989463. [PubMed: 7989463].
  • 31. Liu D, Su L, Han G, Yan P, Xie L. Prognostic value of procalcitonin in adult patients with sepsis: A systematic review and meta-analysis. PLoS One. 2015;10(6). e0129450. doi: 10.1371/journal.pone.0129450. [PubMed: 26076027]. [PubMed Central: PMC4468164].
  • 32. Cousin VL, Lambert K, Trabelsi S, Galetto-Lacour A, Posfay-Barbe KM, Wildhaber BE, et al. Procalcitonin for infections in the first week after pediatric liver transplantation. BMC Infect Dis. 2017;17(1):149. doi: 10.1186/s12879-017-2234-y. [PubMed: 28201980]. [PubMed Central: PMC5311857].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments